Lv1
6 积分 2022-08-22 加入
Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancer
2个月前
已完结
Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancer
2个月前
已完结
A multi-institutional randomized phase III trial of lobectomy versus segmentectomy for radiologically solid-predominant non-small cell lung cancer with a ground-glass opacity and tumor diameter > 2 cm and ≤ 3 cm: JCOG2217 (STRONG)
3个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
6个月前
已完结
Clinical and molecular analysis of two Chinese siblings with Bloom syndrome
8个月前
已完结
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy
10个月前
已完结
Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer
10个月前
已完结
MA11.05 Nivolumab + Ipilimumab vs Chemotherapy in Patients with Stage IV/recurrent NSCLC and PD-L1 ≥ in China: Checkmate 227 CHESS
10个月前
已关闭
The p53-Mdm2 module and the ubiquitin system
10个月前
已完结
皖公网安备34019202002308
